Daiwa Securities Group Inc. Has $503,000 Position in DaVita Inc. (NYSE:DVA)

Daiwa Securities Group Inc. grew its holdings in DaVita Inc. (NYSE:DVA) by 3.7% during the fourth quarter, Holdings Channel reports. The firm owned 4,802 shares of the company’s stock after acquiring an additional 171 shares during the quarter. Daiwa Securities Group Inc.’s holdings in DaVita were worth $503,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Hanseatic Management Services Inc. acquired a new position in DaVita in the third quarter valued at approximately $36,000. FinTrust Capital Advisors LLC increased its stake in shares of DaVita by 242.3% in the 3rd quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock valued at $67,000 after acquiring an additional 504 shares in the last quarter. Federated Hermes Inc. lifted its position in shares of DaVita by 1,284.4% during the 3rd quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock valued at $118,000 after acquiring an additional 1,156 shares during the period. Tacita Capital Inc bought a new position in DaVita during the third quarter worth $118,000. Finally, CENTRAL TRUST Co increased its stake in DaVita by 93.3% in the third quarter. CENTRAL TRUST Co now owns 1,448 shares of the company’s stock valued at $137,000 after purchasing an additional 699 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

Insider Transactions at DaVita

In related news, CEO Javier Rodriguez sold 67,603 shares of the firm’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the transaction, the chief executive officer now directly owns 488,697 shares of the company’s stock, valued at $61,629,578.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other DaVita news, CEO Javier Rodriguez sold 67,603 shares of the stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total value of $8,525,414.33. Following the completion of the sale, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider James O. Hearty sold 26,164 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $119.64, for a total value of $3,130,260.96. Following the completion of the transaction, the insider now owns 20,264 shares in the company, valued at approximately $2,424,384.96. The disclosure for this sale can be found here. Insiders sold a total of 134,540 shares of company stock worth $16,551,071 in the last quarter. 1.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. StockNews.com raised shares of DaVita from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Truist Financial increased their price target on DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a report on Tuesday, February 20th. TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. Barclays initiated coverage on DaVita in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 target price on the stock. Finally, UBS Group boosted their price target on shares of DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $118.50.

DaVita Stock Performance

Shares of DVA opened at $132.77 on Friday. The firm has a market capitalization of $11.64 billion, a P/E ratio of 17.94, a P/E/G ratio of 1.18 and a beta of 1.04. DaVita Inc. has a 52 week low of $71.51 and a 52 week high of $141.54. The stock has a 50 day moving average price of $131.89 and a two-hundred day moving average price of $110.16. The company has a debt-to-equity ratio of 6.65, a quick ratio of 1.13 and a current ratio of 1.19.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, February 13th. The company reported $1.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.53 by $0.34. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The business had revenue of $3.15 billion during the quarter, compared to the consensus estimate of $3.01 billion. During the same quarter in the prior year, the company posted $1.11 earnings per share. DaVita’s revenue was up 7.8% compared to the same quarter last year. Equities analysts forecast that DaVita Inc. will post 9.23 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.